Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation : A randomized clinical trial

JAMA Oncology

Volumn 1, Issue 7, 2015, Pages 931-941

  Shaitelman, Simona F ^a   Schlembach, Pamela J ^a   Arzu, Isidora ^a   Ballo, Matthew ^b   Bloom, Elizabeth S ^a   Buchholz, Daniel ^c   Chronowski, Gregory M ^a   Dvorak, Tomas ^c   Grade, Emily ^d   Hoffman, Karen E ^a   Kelly, Patrick ^c   Ludwig, Michelle ^e   Perkins, George H ^a   Reed, Valerie ^a   Shah, Shalin ^a   Stauder, Michael C ^a   Strom, Eric A ^a   Tereffe, Welela ^a   Woodward, Wendy A ^a   Ensor, Joe ^f   Baumann, Donald ^a   Thompson, Alastair M ^a   Amaya, Diana ^a   Davis, Tanisha ^a   Guerra, William ^a   Hamblin, Lois ^a   Hortobagyi, Gabriel ^a   Hunt, Kelly K ^a   Buchholz, Thomas A ^a   Smith, Benjamin D ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

^d Banner MD Anderson Cancer Center   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PARTIAL MASTECTOMY; PATHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION INJURIES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; DOSE HYPOFRACTIONATION; FEMALE; HUMANS; LOGISTIC MODELS; MASTECTOMY, SEGMENTAL; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ODDS RATIO; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85010685718     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.2666     Document Type: Article

References (31)

1. Haviland JS, Owen JR, Dewar JA, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013; 14 (11): 1086-1094.
2. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010; 362 (6): 513-520.
3. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet Oncol. 2006; 7(6): 467-471.
4. Bekelman JE, Sylwestrzak G, Barron J, et al. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013. JAMA. 2014; 312(23): 2542-2550. doi: 10.1001/jama.2014.16616.
5. Jagsi R, Falchook AD, Hendrix LH, Curry H, Chen RC. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Int J Radiat Oncol Biol Phys. 2014; 90(5): 1001-1009.
6. Jagsi R, Griffith KA, Heimburger D, et al; Michigan Radiation Oncology Quality Consortium. Choosing wisely? patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys. 2014; 90(5): 1010-1016.
7. Wang EH, Mougalian SS, Soulos PR, et al. Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: A National Cancer Data Base analysis. Int J Radiat Oncol Biol Phys. 2014; 90(5): 993-1000. doi: 10.1016/j.ijrobp.2014.06 .038.
8. Mowery YM, Blitzblau RC. Whole-breast radiation therapy: The long and short of it. Int J Radiat Oncol Biol Phys. 2014; 90(5): 990-992.
9. Goffman TE, Glatstein E. Hypofractionation redux? J Clin Oncol. 2004; 22(4): 589-591.
10. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975; 31(1): 103-115.
11. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes. 2003; 1: 79.
12. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat. 1999; 55(2): 189-199.
13. Brady MJ, Cella DF,Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997; 15(3): 974-986.
14. Fairclough DL, Cella DF. Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions. Qual Life Res. 1996; 5(3): 321-329.
15. Stanton AL, Krishnan L, Collins CA. Form or function? part 1: Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001; 91(12): 2273-2281.
16. US Census Bureau. Race. http: //www.census.gov /topics/population/race/about.html. Accessed June 1. 2014.
17. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Am J Clin Nutr. 1998; 68(4): 899-917.
18. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011; 81(1): 59-68.
19. Hahn C, Kavanagh B, Bhatnagar A, et al. Choosing Wisely: The American Society for Radiation Oncology's Top 5 List. http: //www .practicalradonc.org/article/S1879-8500(14) 00164-7/abstract. Accessed July 17, 2015.
20. National Collaborating Centre for Cancer (UK). Early and locally advanced breast cancer: Diagnosis and treatment. http: //www.nice.org.uk/guidance /cg80/chapter/1-recommendations. Accessed June 24, 2015.
21. Ashworth A, KongW, Whelan T, MackillopWJ. A population-based study of the fractionation of postlumpectomy breast radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 86(1): 51-57.
22. Berrang TS, Truong PT, Tyldesley S, Olivotto IA. A population-based study of the fractionation of postlumpectomy breast radiation therapy. In regard toAshworth et al. Int J Radiat Oncol Biol Phys. 2013; 87(4): 632-633.
23. Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer. 2005; 104(8): 1772-1778.
24. Reidunsdatter RJ, Albrektsen G, HjermstadMJ, Rannestad T, Oldervoll LM, Lundgren S. One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients: Comparison to general population. Acta Oncol. 2013; 52(2): 239-248.
25. Reidunsdatter RJ, Rannestad T, Frengen J, Frykholm G, Lundgren S. Early effects of contemporary breast radiation on health-related quality of life - predictors of radiotherapy-related fatigue. Acta Oncol. 2011; 50(8): 1175-1182.
26. Taunk NK, Haffty BG, Chen S, et al. Comparison of radiation-induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer. Cancer. 2011; 117(18): 4116-4124.
27. Wratten C, Kilmurray J, Nash S, et al. Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys. 2004; 59(1): 160-167.
28. Noal S, Levy C, Hardouin A, et al. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011; 81 (3): 795-803.
29. Magnan MA, Mood DW. The effects of health state, hemoglobin, global symptom distress, mood disturbance, and treatment site on fatigue onset, duration, and distress in patients receiving radiation therapy. Oncol Nurs Forum. 2003; 30(2): E33-E39.
30. Hugh Dunstan R, Sparkes DL, Macdonald MM, et al. Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients: A pilot study. Clin Biochem. 2011; 44(2-3): 208-215.
31. Geinitz H, Zimmermann FB, Thamm R, KellerM, Busch R, Molls M. Fatigue in patients with adjuvant radiation therapy for breast cancer: Long-term follow-up. J Cancer Res Clin Oncol. 2004; 130(6): 327-333.